HAVN Life Sciences Stock

HAVN Life Sciences Debt 2025

HAVN Life Sciences Debt

-0.67 CAD

Ticker

HAVN.CN

ISIN

CA4196213058

WKN

A3DR7N

In 2025, HAVN Life Sciences's total debt was -0.67 CAD, a 0% change from the 0 CAD total debt recorded in the previous year.

HAVN Life Sciences Aktienanalyse

What does HAVN Life Sciences do?

HAVN Life Sciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding HAVN Life Sciences's Debt Structure

HAVN Life Sciences's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing HAVN Life Sciences's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to HAVN Life Sciences’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in HAVN Life Sciences’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about HAVN Life Sciences stock

What is the debt of HAVN Life Sciences this year?

HAVN Life Sciences has a debt level of -0.67 CAD this year.

What was the debt of HAVN Life Sciences compared to the previous year?

The debt of HAVN Life Sciences has increased by 0% compared to the previous year dropped.

What are the consequences of high debt for investors in HAVN Life Sciences?

High debt can pose a risk for investors of HAVN Life Sciences, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of HAVN Life Sciences?

Low debt means that HAVN Life Sciences has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from HAVN Life Sciences affect the company?

An increase in debt of HAVN Life Sciences can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of HAVN Life Sciences affect the company?

A reduction in debt of HAVN Life Sciences can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of HAVN Life Sciences?

Some factors that can influence the debt of HAVN Life Sciences include investments, acquisitions, operating costs, and revenue development.

Why are the debts of HAVN Life Sciences so important for investors?

The debts of HAVN Life Sciences are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can HAVN Life Sciences take to change the debt?

To change the debt, HAVN Life Sciences can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does HAVN Life Sciences pay?

Over the past 12 months, HAVN Life Sciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, HAVN Life Sciences is expected to pay a dividend of 0 CAD.

What is the dividend yield of HAVN Life Sciences?

The current dividend yield of HAVN Life Sciences is .

When does HAVN Life Sciences pay dividends?

HAVN Life Sciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of HAVN Life Sciences?

HAVN Life Sciences paid dividends every year for the past 0 years.

What is the dividend of HAVN Life Sciences?

For the upcoming 12 months, dividends amounting to 0 CAD are expected. This corresponds to a dividend yield of 0 %.

In which sector is HAVN Life Sciences located?

HAVN Life Sciences is assigned to the '-' sector.

Wann musste ich die Aktien von HAVN Life Sciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of HAVN Life Sciences from 7/12/2025 amounting to 0 CAD, you needed to have the stock in your portfolio before the ex-date on 7/12/2025.

When did HAVN Life Sciences pay the last dividend?

The last dividend was paid out on 7/12/2025.

What was the dividend of HAVN Life Sciences in the year 2024?

In the year 2024, HAVN Life Sciences distributed 0 CAD as dividends.

In which currency does HAVN Life Sciences pay out the dividend?

The dividends of HAVN Life Sciences are distributed in CAD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von HAVN Life Sciences

Our stock analysis for HAVN Life Sciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of HAVN Life Sciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.